Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemiaN Vey, H Kantarjian, H Tran, et al.
Bone Marrow Transplantation|September 1, 1994
Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remissionN Vey, D Blaise, A M Stoppa, et al.
Bone Marrow Transplantation|November 1, 1994
Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recoveryN Vey, S Molnar, C Faucher, et al.
Leukemia|October 3, 2002
Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysisM Mohty, C Faucher, N Vey, et al.
Bone Marrow Transplantation|October 6, 2010
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCTL Castagna, S Fürst, N Marchetti, et al.
La Revue De Medecine Interne|January 29, 2019
[CAR-T cells: Lymphocytes that express a chimeric antigen receptor]C Chabannon, R Bouabdallah, S Fürst, et al.
Bone Marrow Transplantation|February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCTR Devillier, R Crocchiolo, L Castagna, et al.
Bone Marrow Transplantation|August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationM Mohty, H de Lavallade, C Faucher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patientsN Vey, D Blaise, M Lafage, et al.
European Cytokine Network|February 12, 1998
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantationN Vey, P Viens, C Fossat, et al.
Pageof 7